These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6181535)

  • 1. Identification and characterisation of a prostacyclin-like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand.
    Town MH; Schillinger E; Speckenbach A; Prior G
    Prostaglandins; 1982 Jul; 24(1):61-72. PubMed ID: 6181535
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM; Strange PG
    Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid.
    Blair IA; MacDermot J
    Br J Pharmacol; 1981 Mar; 72(3):435-41. PubMed ID: 6266565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin binding to guinea pig pulmonary receptors.
    MacDermot J; Barnes PJ; Waddell KA; Dollery CT; Blair IA
    Eur J Pharmacol; 1981 Oct; 75(2-3):127-30. PubMed ID: 6274663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 7. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the prostacyclin receptor by radiation inactivation.
    Leigh PJ; Cramp WA; MacDermot J
    J Biol Chem; 1984 Oct; 259(20):12431-6. PubMed ID: 6208187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for high affinity prostacyclin binding sites in vascular tissue: radioligand studies with a chemically stable analogue.
    Rücker W; Schrör K
    Biochem Pharmacol; 1983 Aug; 32(16):2405-10. PubMed ID: 6193794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
    Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
    Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostaglandin interaction in the human liver].
    Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
    Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H] prostaglandins binding to dispersed bovine luteal cells: evidence for discrete prostaglandin receptors.
    Lin MT; Rao CV
    Biochem Biophys Res Commun; 1977 Sep; 78(2):510-6. PubMed ID: 199177
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel subtype of the prostacyclin receptor expressed in the central nervous system.
    Takechi H; Matsumura K; Watanabe Y; Kato K; Noyori R; Suzuki M; Watanabe Y
    J Biol Chem; 1996 Mar; 271(10):5901-6. PubMed ID: 8621463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors and mechanisms of action of prostacyclin in preserving non-mucosal cell integrity.
    Nicosia S; Oliva D; Paoletti R
    Gastroenterol Clin Biol; 1985; 9(12 Pt 2):33-6. PubMed ID: 2422088
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity.
    Skuballa W; Schillinger E; Stürzebecher CS; Vorbrüggen H
    J Med Chem; 1986 Mar; 29(3):313-5. PubMed ID: 2419560
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo.
    MacDermot J
    Biochem Pharmacol; 1986 Aug; 35(16):2645-9. PubMed ID: 2427086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.